References
- Paterson DL. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Med 2006;119(6 Suppl 1):S20–8.
- Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006;14:413–20.
- Cornaglia G, Akova M, Amicosante G, Canton R, Cauda R, Docquier JD, . Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents 2007;29:380–8.
- Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, . Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597–602.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20th informational supplement M100-S20-U. Wayne, PA: CLSI; 2010.
- Pitout JD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, . Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 2007;51:1281–6.
- Peirano G, Ahmed-Bentley J, Woodford N, Pitout JD. New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerg Infect Dis 2011;17:242–4.
- Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006;50:2872–4.
- Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, . Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006;12:83–8.
- Yamane K, Wachino J, Suzuki S, Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 2008;52:1564–6.
- Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006;50:3953–5.
- Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, . Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004;48:3758–64.
- Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005;63:219–28.
- Mnif B, Vimont S, Boyd A, Bourit E, Picard B, Branger C, . Molecular characterization of addiction systems of plasmids encoding extended-spectrum beta-lactamases in Escherichia coli. J Antimicrob Chemother 2010;65: 1599–603.
- Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miriagou V, Kontou S, . VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 2003;41:3893–6.
- Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece—a review of the current evidence. Euro Surveill. 2008;13:8023. Review. PMID:18445397[PubMed - indexed for MEDLINE] Free Article.
- Psichogiou M, Tassios PT, Avlamis A, Stefanou I, Kosmidis C, Platsouka E, . Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother 2008;61:59–63.
- Montealegre MC, Correa A, Briceño DF, Rosas NC, De La Cadena E, Ruiz SJ, Mojica MF, Camargo RD, Zuluaga I, Marin A, Quinn JP, Villegas MV; Colombian Nosocomial Resistance Study Group. Novel VIM metallo-beta-lactamase variant, VIM-24, from a Klebsiella pneumoniae isolate from Colombia. Antimicrob Agents Chemother 2011;55:2428–30. Epub 2011 Jan 31.
- Robin F, Aggoune-Khinache N, Delmas J, Naim M, Bonnet R. Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob Agents Chemother 2010;54:466–70.
- Samuelsen O, Toleman MA, Hasseltvedt V, Fuursted K, Leegaard TM, Walsh TR, Sundsfjord A, Giske CG. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect. 2011 Apr 4. doi: 10.1111/j.1469-0691.2011.03532.x. [Epub ahead of print] PMID:21595797.
- Tato M, Coque TM, Ruiz-Garbajosa P, Pintado V, Cobo J, Sader HS, . Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis 2007;45:1171–8.
- Kassis-Chikhani N, Decre D, Gautier V, Burghoffer B, Saliba F, Mathieu D, . First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital. J Antimicrob Chemother 2006;57:142–5.
- Cagnacci S, Gualco L, Roveta S, Mannelli S, Borgianni L, Docquier JD, . Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak. J Antimicrob Chemother 2008;61:296–300.
- Poulou A, Spanakis N, Pournaras S, Pitiriga V, Ranellou K, Markou F, . Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 2010;65:2538–42.
- Papagiannitsis CC, Giakkoupi P, Vatopoulos AC, Tryfinopoulou K, Miriagou V, Tzouvelekis LS. Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 beta-lactamases. Int J Antimicrob Agents 2010;36:573–4.